Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients

M. Tempestilli, A. Ammassari, A. D'Avolio, S. Cicalini, A.L. Gallo, S. Fazio, A. Antinori, L.P. Pucillo

Research output: Contribution to journalArticlepeer-review

Cite this